Immunoglobulin e and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Wang, Zhen ^a   Zhang, Hong ^a   Shen, Xu Hui ^a   Jin, Kui Li ^b   Ye, Guo fen ^c   Qian, Li ^c   Li, Bo ^d   Zhang, Yong Hong ^e   Shi, Guo Ping ^f  

^a HUZHOU UNIVERSITY   (China)

^b Huzhou Center for Disease Prevention and Control   (China)

^c Aishan Street Community Health Center ^*  (China)

^d Huanzhu Rural Hospital   (China)

^e MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHYMASE; IMMUNOGLOBULIN E; TRYPTASE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NONHUMAN; RISK FACTOR; ANTHROPOMETRY; BLOOD; ENZYMOLOGY; IMMUNOLOGY; MALE; MAST CELL; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

AGED; ANTHROPOMETRY; C-REACTIVE PROTEIN; CHYMASES; DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOGLOBULIN E; LOGISTIC MODELS; MALE; MAST CELLS; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS; TRYPTASES;

EID: 83455221081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028962     Document Type: Article

References (44)

1. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, et al. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353: 1649-1652.
2. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, et al. (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50: 2384-2389.
3. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334.
4. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
5. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE, (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700.
6. Meigs JB, Hu FB, Rifai N, Manson JE, (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291: 1978-1986.
7. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, et al. (2011) Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 54: 767-775.
8. Theoharides TC, Kalogeromitros D, (2006) The critical role of mast cells in allergy and inflammation. Ann N Y Acad Sci 1088: 78-99.
9. Bradding P, Walls AF, Holgate ST, (2006) The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117: 1277-1284.
10. Liu J, Divoux A, Sun J, Zhang J, Clément K, et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 15: 940-945.
11. Sun J, Zhang J, Lindholt JS, Sukhova GK, Liu J, et al. (2009) Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 120: 973-982.
12. Zhang J, Sun J, Lindholt JS, Sukhova GK, Sinnamon M, et al. (2011) Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ Res 108: 1316-1327.
13. MacGlashan D Jr, Lavens-Phillips S, Katsushi M, (1998) IgE-mediated desensitization in human basophils and mast cells. Front Biosci 3: d746-d756.
14. Gruber B, (1989) Activation of rheumatoid synovial mast cells. Role of IgE-associated antiglobulins. Monogr Allergy 26: 120-134.
15. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, et al. (2003) C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88: 3507-3512.
16. Pickup JC, (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823.
17. Wellen KE, Hotamisligil GS, (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
18. Xiang M, Sun J, Lin Y, Zhang J, Chen H, et al. (2011) Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis 215: 494-499.
19. Wang J, Cheng X, Xiang MX, Alanne-Kinnunen M, Wang JA, et al. (2011) IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. J Clin Invest 121: 3564-3577.
20. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
21. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
22. Mayor S, (2007) International Diabetes Federation consensus on prevention of type 2 diabetes. Int J Clin Pract 61: 1773-1775.
23. Wu Y, Huxley R, Li L, Anna V, Xie G, et al. (2008) Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 118: 2679-2686.
24. Zhang P, Jiao S, Zhou Y, (2007) Study on chronic disease related behaviour and lifestyle in adults in Beijing. Chin J Epidemiol 28: 1162-1166.
25. Haffner SM, (2003) Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 61 (Suppl 1): S9-S18.
26. Ndumele CE, Pradhan AD, Ridker PM, (2006) Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr 1: 190-196.
27. Haffner SM, (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97: 3A-11A.
28. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, et al. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600.
29. Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, et al. (2005) Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 82: 675-684.
30. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, et al. (2002) Tanis: a link between type 2 diabetes and inflammation? Diabetes 51: 1859-1866.
31. Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, et al. (2008) Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51: 502-511.
32. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, et al. (2006) Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 55: 3536-3549.
33. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA, (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55: 1430-1435.
34. Wasada T, Kuroki H, Katsumori K, Arii H, Sato A, et al. (2004) Who are more insulin resistant, people with IFG or people with IGT? Diabetologia 47: 758-759.
35. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R, et al. (2003) The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52: 1475-1484.
36. Festa A, D'Agostino R, Tracy RP, Haffner SM, Insulin Resistance Atherosclerosis Study (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51: 1131-1137.
37. Kim JK, (2010) Inflammation and insulin resistance: an old story with new ideas. Korean Diabetes J 34: 137-145.
38. Sommer P, Sweeney G, (2010) Functional and mechanistic integration of infection and the metabolic syndrome. Korean Diabetes J 34: 71-76.
39. Ikeoka D, Mader JK, Pieber TR, (2010) Adipose tissue, inflammation and cardiovascular disease. Rev Assoc Med Bras 56: 116-121.
40. Yang M, Zhang Y, Pan J, Sun J, Liu J, et al. (2007) Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 9: 970-977.
41. Yang M, Sun J, Zhang T, Liu J, Zhang J, et al. (2008) Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol 28: 2202-2208.
42. Kovanen PT, Mänttäri M, Palosuo T, Manninen V, Aho K, (1998) Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med 158: 1434-1439.
43. Erdogan O, Altun A, Gul C, Ozbay G, (2003) C-reactive protein and immunoglobulin-E response to coronary artery stenting in patients with stable angina. Jpn Heart J 44: 593-600.
44. Shahzad F, Tawwab S, Afzal N, (2010) Association of interleukin-4 and IgE levels with LDL oxidation in atherosclerosis. Iran J Immunol 7: 109-116.